{"id":4071,"date":"2025-11-24T09:46:52","date_gmt":"2025-11-24T09:46:52","guid":{"rendered":"https:\/\/network.rvrising.com\/?p=4071"},"modified":"2025-11-24T09:46:52","modified_gmt":"2025-11-24T09:46:52","slug":"kessler-topaz-meltzer-check-llp-encourages-dexcom-inc-dxcm-investors-to-contact-the-firm-about-securities-fraud-class-action-lawsuit","status":"publish","type":"post","link":"https:\/\/www.rvrising.com\/news\/business\/kessler-topaz-meltzer-check-llp-encourages-dexcom-inc-dxcm-investors-to-contact-the-firm-about-securities-fraud-class-action-lawsuit\/","title":{"rendered":"Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (DXCM) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit"},"content":{"rendered":"

RADNOR, Pa.<\/span>, Nov. 22, 2025<\/span> \/PRNewswire\/ — The law firm of Kessler Topaz Meltzer & Check, LLP<\/a>\u00a0(www.ktmc.com<\/a>) informs investors that securities class action lawsuits have been filed against\u00a0DexCom, Inc. (“DexCom”) (NASDAQ: <\/a>DXCM<\/a>) on behalf of those who purchased or otherwise acquired DexCom securities between January 8, 2024, and September 17, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is December 26, 2025.<\/b><\/p>\n

\n

CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:\u00a0 \u00a0
<\/u><\/b>If you suffered DexCom losses, <\/b>you may<\/b>\u00a0CLICK HERE<\/a>\u00a0or copy and paste the following link into your browser: <\/b>https:\/\/www.ktmc.com\/new-cases\/dexcom-inc-1?utm_source=PR_Newswire&mktm=PR<\/a><\/p>\n

You can also contact attorney\u00a0<\/b>Jonathan Naji, Esq.<\/a> by calling (484) 270-1453 or by email at <\/b>[email\u00a0protected]<\/span><\/a>.<\/p>\n

DEFENDANTS’ ALLEGED<\/span> MISCONDUCT:
<\/u><\/b>The complaints allege<\/span> that, throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that: (1) DexCom had made material design changes to its G6 and G7 continuous glucose monitoring systems that were unauthorized by the FDA; (2) the foregoing design changes rendered the G6 and G7 less reliable than their prior iterations, presenting a material health risk to users relying on those devices for accurate glucose readings; (3) DexCom’s purported enhancements to the G7, as well as the device’s reliability, accuracy, and functionality, were overstated; (4) DexCom downplayed the true scope and severity of the issues and health risks posed by adulterated G7 devices; (5) all the foregoing subjected DexCom to an increased risk of heightened regulatory scrutiny and enforcement action, as well as significant legal, reputational, and financial harm; and (6) as a result, Defendants’ public statements were materially false and\/or misleading at all relevant times.<\/p>\n

Please<\/b> CLICK HERE<\/a> to view our video or copy and paste this link into your browser:\u00a0 <\/b>https:\/\/youtube.com\/shorts\/ToTm4-K0ODs?feature=share<\/a><\/p>\n

THE LEAD PLAINTIFF PROCESS:
<\/u><\/b>DexCom\u00a0investors may, no later than December 26, 2025,<\/u><\/i><\/b> seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP<\/a>\u00a0or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.\u00a0 The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.<\/p>\n

Kessler Topaz Meltzer & Check, LLP<\/a>\u00a0encourages DexCom investors who have suffered significant losses to contact the firm directly to acquire more information.<\/p>\n

CLICK HERE<\/a><\/b>\u00a0TO SIGN UP FOR THE CASE<\/b>\u00a0OR GO TO: <\/b>https:\/\/www.ktmc.com\/new-cases\/dexcom-inc-1?utm_source=PR_Newswire&mktm=PR<\/a><\/p>\n

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
<\/u><\/b>Kessler Topaz Meltzer & Check, LLP<\/a>\u00a0prosecutes class actions in state and federal courts throughout the country and around the world.\u00a0 The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud<\/span> and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud<\/span>, abuse, misconduct and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP<\/a>\u00a0please visit www.ktmc.com<\/a>.<\/p>\n

CONTACT:
<\/b>Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
[email\u00a0protected]<\/span><\/a><\/p>\n

May be considered attorney advertising in certain jurisdictions.\u00a0 Past results do not guarantee future outcomes.<\/p>\n

SOURCE Kessler Topaz Meltzer & Check, LLP<\/p>\n<\/div>\n

This release is auto-published via PR Newswire; our journal is not responsible for the content.<\/b><\/p>\n

Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

RADNOR, Pa., Nov. 22, 2025 \/PRNewswire\/ — The law firm of Kessler Topaz Meltzer & Check, LLP\u00a0(www.ktmc.com) informs<\/p>\n","protected":false},"author":1,"featured_media":4072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8,92],"tags":[246,44],"class_list":["post-4071","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-pr-newswire","tag-kessler-topaz-meltzer-check","tag-llp"],"_links":{"self":[{"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/posts\/4071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/comments?post=4071"}],"version-history":[{"count":1,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/posts\/4071\/revisions"}],"predecessor-version":[{"id":4162,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/posts\/4071\/revisions\/4162"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/media\/4072"}],"wp:attachment":[{"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/media?parent=4071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/categories?post=4071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/tags?post=4071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}